Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
48,204,313
-
Share change
-
+446,582
-
Total reported value
-
$4,593,364,866
-
Put/Call ratio
-
85%
-
Price per share
-
$95.27
-
Number of holders
-
233
-
Value change
-
+$46,875,634
-
Number of buys
-
137
-
Number of sells
-
91
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q2 2020
As of 30 Jun 2020,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
233 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,204,313 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, ALKEON CAPITAL MANAGEMENT LLC, Artal Group S.A., STATE STREET CORP, and Avoro Capital Advisors LLC.
This page lists
233
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.